Search results
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 4 hours agoModerna compared the immune response between those who were given mRNA-1083 versus those who were...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 15 hours agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
US News & World Report· 7 hours agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna ...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 9 hours agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Combined COVID-flu vaccine shows positive results in late-stage trial, Moderna says
WISH-TV Indianapolis· 8 hours agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 4 hours agoModerna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial,...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
ABC News· 9 hours agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Moderna's Combo Flu/Covid Shot Topped Rivals From Sanofi, GSK
Investor's Business Daily· 9 hours agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 10 hours agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 9 hours agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...